Published in Front Physiol on February 25, 2013
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science (2006) 25.99
Hepatocellular carcinoma. N Engl J Med (2011) 19.40
The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science (2002) 13.86
Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci U S A (2007) 11.46
Gene expression patterns in human liver cancers. Mol Biol Cell (2002) 6.93
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene (2006) 6.61
Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature (1991) 6.16
An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell (2008) 5.47
Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A (1998) 4.99
Network-based prediction of human tissue-specific metabolism. Nat Biotechnol (2008) 4.39
Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet (2003) 3.93
Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology (2007) 3.85
Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res (2001) 3.18
Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology (2002) 2.68
Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism. Mol Syst Biol (2010) 2.60
Prediction and validation of cell alignment along microvessels as order principle to restore tissue architecture in liver regeneration. Proc Natl Acad Sci U S A (2010) 2.50
Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma. Hepatology (2012) 2.40
Genetics of hepatocellular carcinoma. Semin Cancer Biol (2000) 2.30
Molecular-based prediction of early recurrence in hepatocellular carcinoma. J Hepatol (2004) 2.10
NF-kappaB in cancer: a marked target. Semin Cancer Biol (2003) 2.08
HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology. Mol Syst Biol (2010) 2.05
Networks inferred from biochemical data reveal profound differences in toll-like receptor and inflammatory signaling between normal and transformed hepatocytes. Mol Cell Proteomics (2010) 1.77
Staging systems in hepatocellular carcinoma. HPB (Oxford) (2005) 1.71
Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade--results of an explorative CGH meta-analysis. Br J Cancer (2005) 1.64
Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res (2002) 1.64
Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol (2002) 1.52
Identification of potential driver genes in human liver carcinoma by genomewide screening. Cancer Res (2009) 1.45
Comparing signaling networks between normal and transformed hepatocytes using discrete logical models. Cancer Res (2011) 1.45
Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res (1994) 1.34
Toward an understanding of the protein interaction network of the human liver. Mol Syst Biol (2011) 1.24
Lessons from mathematically modeling the NF-κB pathway. Immunol Rev (2012) 1.22
METABOLIC CONTROL MECHANISMS. VII.A DETAILED COMPUTER MODEL OF THE GLYCOLYTIC PATHWAY IN ASCITES CELLS. J Biol Chem (1964) 1.21
Gene expression profile linked to p53 status in hepatitis C virus-related hepatocellular carcinoma. FEBS Lett (2003) 1.15
Integrative network analysis identifies key genes and pathways in the progression of hepatitis C virus induced hepatocellular carcinoma. BMC Med Genomics (2011) 1.02
A human model of epithelial to mesenchymal transition to monitor drug efficacy in hepatocellular carcinoma progression. Mol Cancer Ther (2011) 1.01
Quantitative analysis of phosphopeptides in search of the disease biomarker from the hepatocellular carcinoma specimen. Proteomics (2009) 0.99
Attenuated phosphorylation of heat shock protein 27 correlates with tumor progression in patients with hepatocellular carcinoma. Biochem Biophys Res Commun (2005) 0.99
Liverbase: a comprehensive view of human liver biology. J Proteome Res (2010) 0.96
Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C. Hepatology (2006) 0.95
iCOD: an integrated clinical omics database based on the systems-pathology view of disease. BMC Genomics (2010) 0.95
A systems biology-based classifier for hepatocellular carcinoma diagnosis. PLoS One (2011) 0.90
Quantitative proteomics reveal up-regulated protein expression of the SET complex associated with hepatocellular carcinoma. J Proteome Res (2011) 0.88
Genetic alterations in liver carcinogenesis: implications for new preventive and therapeutic strategies. Crit Rev Oncog (2000) 0.88
Subcellular tissue proteomics of hepatocellular carcinoma for molecular signature discovery. J Proteome Res (2011) 0.86
Library of molecular associations: curating the complex molecular basis of liver diseases. BMC Genomics (2010) 0.81
A mathematical model for the dynamics of cancer hepatocytes under therapeutic actions. J Theor Biol (2011) 0.79
Histological and genetic heterogeneity in synchronous hepatocellular carcinoma. Gut (2001) 0.77
Systems biology approaches to decoding the genome of liver cancer. Cancer Res Treat (2011) 0.76
A mouse model for visualization and conditional mutations in the erythroid lineage. Blood (2004) 2.41
The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. J Clin Invest (2011) 2.30
Covering a broad dynamic range: information processing at the erythropoietin receptor. Science (2010) 1.65
Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling. Blood (2014) 1.50
Division of labor by dual feedback regulators controls JAK2/STAT5 signaling over broad ligand range. Mol Syst Biol (2011) 1.45
Theoretical and experimental analysis links isoform-specific ERK signalling to cell fate decisions. Mol Syst Biol (2009) 1.31
Lessons learned from quantitative dynamical modeling in systems biology. PLoS One (2013) 1.28
Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2. Blood (2008) 1.20
The glucocorticoid receptor controls hepatic dyslipidemia through Hes1. Cell Metab (2008) 1.15
Computational processing and error reduction strategies for standardized quantitative data in biological networks. FEBS J (2005) 1.13
The interface between self-assembling erythropoietin receptor transmembrane segments corresponds to a membrane-spanning leucine zipper. J Biol Chem (2003) 1.08
The virtual liver: state of the art and future perspectives. Arch Toxicol (2014) 1.05
Dynamic pathway modeling: feasibility analysis and optimal experimental design. Ann N Y Acad Sci (2007) 1.04
Transcription factors KLF1 and KLF2 positively regulate embryonic and fetal beta-globin genes through direct promoter binding. J Biol Chem (2011) 1.01
The microtubule affinity regulating kinase MARK4 promotes axoneme extension during early ciliogenesis. J Cell Biol (2013) 1.01
Forced dimerization of gp130 leads to constitutive STAT3 activation, cytokine-independent growth, and blockade of differentiation of embryonic stem cells. Mol Biol Cell (2006) 1.00
Effects of telomerase modulation in human hematopoietic progenitor cells. Stem Cells (2004) 0.98
Erythropoiesis and globin switching in compound Klf1::Bcl11a mutant mice. Blood (2013) 0.94
Quantitative protein microarrays for time-resolved measurements of protein phosphorylation. Proteomics (2008) 0.93
Dynamic mathematical modeling of IL13-induced signaling in Hodgkin and primary mediastinal B-cell lymphoma allows prediction of therapeutic targets. Cancer Res (2010) 0.92
Quenched substrates for live-cell labeling of SNAP-tagged fusion proteins with improved fluorescent background. Anal Chem (2010) 0.91
Knowledge-based matrix factorization temporally resolves the cellular responses to IL-6 stimulation. BMC Bioinformatics (2010) 0.91
Heterogeneous kinetics of AKT signaling in individual cells are accounted for by variable protein concentration. Front Physiol (2012) 0.89
Combining theoretical analysis and experimental data generation reveals IRF9 as a crucial factor for accelerating interferon α-induced early antiviral signalling. FEBS J (2010) 0.89
Standardizing experimental protocols. Curr Opin Biotechnol (2008) 0.89
Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts. J Nucl Med (2012) 0.87
A rapidly reversible chemical dimerizer system to study lipid signaling in living cells. Angew Chem Int Ed Engl (2014) 0.87
An integrative model links multiple inputs and signaling pathways to the onset of DNA synthesis in hepatocytes. FEBS J (2012) 0.86
A systems biology approach to analyse amplification in the JAK2-STAT5 signalling pathway. BMC Syst Biol (2008) 0.86
A functional green fluorescent protein-erythropoietin receptor despite physical separation of JAK2 binding site and tyrosine residues. J Biol Chem (2002) 0.85
One-source peptide/phosphopeptide standards for accurate phosphorylation degree determination. Proteomics (2011) 0.85
Report on EU-USA workshop: how systems biology can advance cancer research (27 October 2008). Mol Oncol (2008) 0.84
Dynamics and feedback loops in the transforming growth factor β signaling pathway. Biophys Chem (2012) 0.83
Cellular ERK phospho-form profiles with conserved preference for a switch-like pattern. J Proteome Res (2012) 0.83
Vegf regulates embryonic erythroid development through Gata1 modulation. Blood (2010) 0.83
Systems biology of JAK/STAT signalling. Essays Biochem (2008) 0.82
The cytokine-inducible Scr homology domain-containing protein negatively regulates signaling by promoting apoptosis in erythroid progenitor cells. J Biol Chem (2002) 0.82
Packing density of the erythropoietin receptor transmembrane domain correlates with amplification of biological responses. Biochemistry (2008) 0.80
In silico labeling reveals the time-dependent label half-life and transit-time in dynamical systems. BMC Syst Biol (2012) 0.80
Identification of isoform-specific dynamics in phosphorylation-dependent STAT5 dimerization by quantitative mass spectrometry and mathematical modeling. J Proteome Res (2014) 0.80
Model-based extension of high-throughput to high-content data. BMC Syst Biol (2010) 0.79
Towards hydrodynamics without an entropy current. Phys Rev Lett (2012) 0.79
Hepatocyte-specific S100a8 and S100a9 transgene expression in mice causes Cxcl1 induction and systemic neutrophil enrichment. Cell Commun Signal (2012) 0.78
Prognostic significance of erythropoietin in pancreatic adenocarcinoma. PLoS One (2011) 0.78
Receptor dynamics in signaling. Adv Exp Med Biol (2012) 0.78
Theoretical analysis of time-to-peak responses in biological reaction networks. Bull Math Biol (2010) 0.77
T160‐phosphorylated CDK2 defines threshold for HGF dependent proliferation in primary hepatocytes. Mol Syst Biol (2015) 0.77
A Systems Biology Study on NFκB Signaling in Primary Mouse Hepatocytes. Front Physiol (2012) 0.76
Excemplify: a flexible template based solution, parsing and managing data in spreadsheets for experimentalists. J Integr Bioinform (2013) 0.75
Spacetime emergence of the robertson-walker universe from a matrix model. Phys Rev Lett (2007) 0.75